Cipla Limited (NSE: CIPLA)
India
· Delayed Price · Currency is INR 1,440.00
-5.45 (-0.38%)
Jan 21, 2025, 10:56 AM IST
Cipla Revenue
Cipla had revenue of 69.61B INR in the quarter ending September 30, 2024, with 5.65% growth. This brings the company's revenue in the last twelve months to 262.64B, up 7.90% year-over-year. In the fiscal year ending March 31, 2024, Cipla had annual revenue of 255.37B with 13.20% growth.
Revenue (ttm)
262.64B
Revenue Growth
+7.90%
P/S Ratio
4.39
Revenue / Employee
9.46M
Employees
27,764
Market Cap
1,153.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 255.37B | 29.77B | 13.20% |
| Mar 31, 2023 | 225.59B | 8.51B | 3.92% |
| Mar 31, 2022 | 217.08B | 25.87B | 13.53% |
| Mar 31, 2021 | 191.21B | 20.40B | 11.94% |
| Mar 31, 2020 | 170.81B | 7.57B | 4.64% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 503.08B |
| Divi's Laboratories | 86.14B |
| Mankind Pharma | 110.18B |
| Zydus Lifesciences | 214.84B |
| Apollo Hospitals Enterprise | 204.69B |
| Aurobindo Pharma | 302.95B |
| Alkem Laboratories | 128.32B |
| Fortis Healthcare | 73.13B |
Cipla News
- 7 days ago - Top stocks to watch in trade today: Hero MotoCorp, Cipla, Blue Dart, ASK Auto, Optiemus, Sula Vineyards, Hathway Cable, MTNL, Innova Captab and more - Business Upturn
- 13 days ago - Pharma stocks: Dr. Reddy’s up 1.70%, Biocon down 2.17%, Lupin falls 2.18% - Business Upturn
- 25 days ago - Healthcare Sector Stock Update: Sun Pharma up 1.05%, Cipla up 1.22%, Zydus Lifesciences up 2% - Business Upturn
- 4 weeks ago - Nifty 50 top gainers this week: Dr. Reddy’s Laboratories and Cipla shine amid market turmoil - Business Upturn
- 4 weeks ago - Nifty 50 top gainers today on December 19: Dr. Reddy’s Laboratories, Cipla, Bharat Petroleum and more - Business Upturn
- 4 weeks ago - Nifty 50 top gainers today on December 18: Trent, Dr. Reddy’s Laboratories, Cipla and more - Business Upturn
- 5 weeks ago - Cipla shares surge after Kotak upgrades stock to Buy from Add, target price at Rs 1,725 - Business Upturn
- 5 weeks ago - Pharma Sector Stocks: Torrent Pharma (+0.25%) rises; Glenmark (-2.29%), Aurobindo (-2.02%) decline - Business Upturn